Send the following on WhatsApp
Continue to ChatRevolution Medicines 獲 2.38億美元投入KRAS相關藥物臨床 https://geneonline.news/revolution-medicines-focus-on-kras-inhibitors/
Revolution Medicines 獲 2.38億美元投入KRAS相關藥物臨床 https://geneonline.news/revolution-medicines-focus-on-kras-inhibitors/